ImmunoGen, Inc. beats by $0.22, beats on revenue

ImmunoGen, Inc. (IMGN): FQ2 EPS of $0.04 beats by $0.22.

Revenue of $30.1M (+1057.7% Y/Y) beats by $11.94M.

From other sites
Comments (3)
  • Scrying Biotech
    , contributor
    Comments (2713) | Send Message
    That is a huge revenue beat. Congratulations ImmunoGen! Get ready to fly today.
    31 Jan 2014, 07:06 AM Reply Like
  • krk
    , contributor
    Comments (854) | Send Message
    Puzzling indifference by the market!
    6 Feb 2014, 05:14 PM Reply Like
  • Mickey one
    , contributor
    Comment (1) | Send Message
    It's about time!
    2 Feb 2014, 12:35 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs